Metrics/Indicators . | . | CHA NCQA III Recognized . | CHA Nonrecognized . |
---|---|---|---|
Cancer preventiona | Colorectal cancer screening | 67% | 65% |
PAP screening | 89% | 82% | |
Diabetes managementa | Blood pressure control | 74% | 66% |
2 HgbA1C tests, past 12 months | 88% | 87% | |
HgbA1C ≤9, past 12 months | 84% | 78% | |
LDL <100, past 12 months | 64% | 56% | |
Perfect Care: 1 LDL exam; 1 Eye exam; 2 HgbA1C tests; 1 micro. test, all last 12 months | 63% | 59% | |
Depression managementa | 50% reduction in PHQ-9 score | 29% | 12% |
New episodes, antidepressant started, with 3 or more contacts in first 16 weeks | 38% | 30% | |
Accessa | Rate provider-canceled encounters | 3% | 4% |
Days to next available appt. after discharge | 6 days | 9 days |
Metrics/Indicators . | . | CHA NCQA III Recognized . | CHA Nonrecognized . |
---|---|---|---|
Cancer preventiona | Colorectal cancer screening | 67% | 65% |
PAP screening | 89% | 82% | |
Diabetes managementa | Blood pressure control | 74% | 66% |
2 HgbA1C tests, past 12 months | 88% | 87% | |
HgbA1C ≤9, past 12 months | 84% | 78% | |
LDL <100, past 12 months | 64% | 56% | |
Perfect Care: 1 LDL exam; 1 Eye exam; 2 HgbA1C tests; 1 micro. test, all last 12 months | 63% | 59% | |
Depression managementa | 50% reduction in PHQ-9 score | 29% | 12% |
New episodes, antidepressant started, with 3 or more contacts in first 16 weeks | 38% | 30% | |
Accessa | Rate provider-canceled encounters | 3% | 4% |
Days to next available appt. after discharge | 6 days | 9 days |
. | . | CHA NCQA III Recognized . | MA Multipayer . |
---|---|---|---|
Patient Experienceb | Overall experience with primary care site | 94% | 88% |
. | . | CHA NCQA III Recognized . | MA Multipayer . |
---|---|---|---|
Patient Experienceb | Overall experience with primary care site | 94% | 88% |